What is the current price / NAV of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The current NAV of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is ₹38.22, as of 3rd February 2026.What are the returns of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund was launched on 13th July 2018. This mutual fund's past returns are as follows:- 1 Year Returns: 3.38%
- 3 Year Returns: 27.32%
- 5 Year Returns: 16.78%
What are the top 5 sectoral holdings of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The top sectors ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund has invested in are as follows:- Pharmaceuticals | 83.54%
- Others | 5.18%
- Labs & Life Sciences Services | 3.64%
- Miscellaneous | 2.85%
- Commodities Trading | 1.53%
What are the top 5 holdings of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The top 5 holdings for ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund are as follows:- Sun Pharmaceutical Industries Ltd | 12.05%
- Cipla Ltd | 7.90%
- Dr Reddy's Laboratories Ltd | 7.82%
- Divi's Laboratories Ltd | 7.10%
- Mankind Pharma Ltd | 6.44%
What is the asset allocation of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The asset allocation for ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is as follows:- Equity | 97.87%
- Cash & Equivalents | 2.13%
What is the AUM of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The AUM (i.e. assets under management) of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is ₹6455.55 Cr as of 3rd February 2026.What is the expense ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The expense ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund Plan is 1.86 as of 3rd February 2026.What is the alpha ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The alpha ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 0.14
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The volatility or standard deviation for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 14.22
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The Sharpe ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is -0.15
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The Sortino Ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is -0.01
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund?
The PE ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund is 32.17, while category PE ratio is 42.16.

Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%